USA - NASDAQ:MBIO - US62818Q3020 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to MBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-24 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | BTIG | Maintains | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-16 | BTIG | Maintains | Buy |
| 2023-06-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-16 | BTIG | Maintains | Buy |
| 2022-01-24 | B. Riley Securities | Maintains | Buy |
| 2021-05-18 | BTIG | Initiate | Buy |
The consensus rating for MUSTANG BIO INC (MBIO) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering MUSTANG BIO INC (MBIO) is 7.